| Literature DB >> 34529467 |
Edoardo Del Poggetto1, I-Lin Ho1,2, Chiara Balestrieri3,4, Er-Yen Yen1,2, Shaojun Zhang1, Francesca Citron1, Rutvi Shah1,2, Denise Corti1, Giuseppe R Diaferia5, Chieh-Yuan Li1,2, Sara Loponte1, Federica Carbone1, Yoku Hayakawa6, Giovanni Valenti6, Shan Jiang1, Luigi Sapio1, Hong Jiang1, Prasenjit Dey7, Sisi Gao1, Angela K Deem1, Stefan Rose-John8, Wantong Yao9, Haoqiang Ying10, Andrew D Rhim11, Giannicola Genovese12, Timothy P Heffernan13, Anirban Maitra14, Timothy C Wang6, Linghua Wang1, Giulio F Draetta1, Alessandro Carugo13, Gioacchino Natoli5,15, Andrea Viale1.
Abstract
Inflammation is a major risk factor for pancreatic ductal adenocarcinoma (PDAC). When occurring in the context of pancreatitis, KRAS mutations accelerate tumor development in mouse models. We report that long after its complete resolution, a transient inflammatory event primes pancreatic epithelial cells to subsequent transformation by oncogenic KRAS. Upon recovery from acute inflammation, pancreatic epithelial cells display an enduring adaptive response associated with sustained transcriptional and epigenetic reprogramming. Such adaptation enables the reactivation of acinar-to-ductal metaplasia (ADM) upon subsequent inflammatory events, thereby limiting tissue damage through a rapid decrease of zymogen production. We propose that because activating mutations of KRAS maintain an irreversible ADM, they may be beneficial and under strong positive selection in the context of recurrent pancreatitis.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34529467 DOI: 10.1126/science.abj0486
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728